Nutritional supplement for reducing side effects from radiation to the belly or pelvis
Part of Cancer, Digestive system, Injuries & trauma clinical trials.
This trial is studying whether a nutritional supplement (a type of short-chain fatty acid) can help reduce the side effects of radiation therapy for cancers in the abdomen or pelvis. It aims to improve quality of life during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosed with a gastrointestinal, urologic, or gynecologic cancer (including sarcoma).
- Scheduled to receive a minimum dose of radiation to the abdomen or pelvis.
- 18 years or older with an ECOG performance status of 0-2 (able to carry out daily activities and light chores).
- No history of inflammatory bowel disease (like Crohn's or ulcerative colitis), chronic diarrhea, or a severe nut allergy.
- Women of childbearing potential must have a negative pregnancy test and use effective contraception; men with partners of childbearing potential must use contraception.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a special dietary supplement can help protect the rectum from radiation damage during chemoradiation for locally advanced rectal cancer. If it works, it may reduce painful bowel symptoms like frequent stools and cramping.
This study tests a combination of a special diet supplement (beta-hydroxybutyrate), short radiation therapy, immunotherapy, and chemotherapy before surgery for locally advanced rectal cancer. The goal is to see if this approach helps shrink the tumor and improve treatment outcomes.
This trial tests an oral probiotic (a mix of 5 good bacteria) to see if it can reduce stomach and bowel side effects from pelvic radiation. It may help people undergoing radiation for certain pelvic cancers.
This study looks at how a hormone called GLP-2 (which helps protect the gut) changes during radiation therapy to the belly or pelvis, and whether it relates to side effects like radiation enteritis (inflammation of the gut). The goal is to better understand and possibly predict these side effects to improve care.
This trial tests a dietary supplement to help heal damage inside the rectum caused by pelvic radiation therapy. If you have mild to moderate rectal bleeding but no signs of cancer recurrence, you may be able to join.
This trial tests a shorter course of radiation to the pelvis to treat rectal cancer, with the goal of avoiding surgery and preserving the rectum. It may be an option for people with advanced rectal cancer that has not spread to other organs.
Hear when a new Toxicity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.